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A system is described which permits the efficient synthesis of
single proteins in vitro. The essential element in this expres-
sion system is a strong promoter derived from coliphage T5
which produces, with high efficiency, specific RNAs in
capped or uncapped form, depending upon the experimental
conditions used. The transcription-coupled capping of RNA
allows the direct translation of the RNA in eukaryotic ex-
tracts from wheat germ as well as from HeLa cells. The syn-
thesis of three different proteins is reported, including lyso-
zyme, which is shown to be translocated across membranes
when appropriate assay conditions are used. The simplicity of
the experimental procedure, the high purity and specific ac-
tivity of the [35S]methionine-labefled proteins produced offer
a number of possibilities for the study of structure-function
relationships of proteins.
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Introduction
Cell-free protein synthesizing systems have been instrumental
in studying mechanisms of protein biosynthesis. They have
also proved to be important tools for the analysis of mem-
brane biogenesis and the translocation of proteins across, or
integration into, membranes (Blobel and Dobberstein, 1975;
see Sabatini et al., 1982). A prerequisite in many of these
studies is the availability of individual well defined mRNA
species. There are, however, only a few cases in which suit-
able mRNA species can easily be purified from specialized
tissues or cell lines.
With the advent of efficient cDNA cloning and screening
methods, it became feasible in principle to produce defined
transcripts of any sequence encoding a protein of interest.
Furthermore, proteins can be produced from modified DNA
and subsequently tested in biological assays. Such an ap-
proach has already provided valuable information on struc-
tural features of signal sequences (Silhavy et al., 1977; Bedou-
elle et al., 1980). What is now required is a simple efficient
system in which selected DNA segments car be transcribed
into functional mRNA and these then translated into pro-
teins. An 'ideal' in vitro expression system would express a
single protein species from cloned DNA in both prokaryotic
and eukaryotic lysates in a quick and simple procedure.
Here we describe a method which permits the production
of single proteins in coupled transcription-translation systems
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of pro- and eukaryotic origin (Roberts et al., 1975; Yang
et at., 1980; Paterson and Rosenberg, 1979). The salient
feature of the system is the highly selective and efficient syn-
thesis of mRNA using a promoter of coliphage T5 (Bujard,
1980) which, depending upon the experimental conditions,
produces capped or uncapped mRNA in high yields.
Results
The experimental design
The most important step in the exclusive expression of a
single protein species in vitro is the selective transcription of
the gene of interest. This is achieved by cloning the proper
sequence into the plasmid pDS6 whose main properties are as
follows (see also Figure 1). (i) It contains multiple insertion
sites between the strong coliphage promoter PN25X/O and
phage X terminator to (Figure 2). (ii) Downstream of to is
located the promoter-free gene of chloramphenicol acetyl-
transferase (cat), which carries its own ribosomal binding site
(RBS) and which is followed by a second terminator. (iii) The
replication region (orn) and the j3-lactamase gene (bla) are
pBR322 derived. (iv) Using the proper in vitro transcription
conditions, PN25X/O outcompetes the ,B-lactamase promoter
20-fold, thus, -95Vo of potentially translatable RNA is
specified by the phage promoter. (v) There is no ATG be-
tween the transcriptional start sequence and the most distal
site for gene insertion. (vi) Under conditions described in
Materials and methods PN25x/O efficiently initiates tran-
scripts with 7mGpppA resulting in capped mRNAs.
A foreign gene integrated downstream of the phage pro-
moter can be expressed in in vitro systems with high effic-
iency using Escherichia coli RNA polymerase for transcrip-
tion and purified pro- or eukaryotic cell lysates for trans-
lation. Supplying [35S]methionine, the protein of interest can
be obtained as labelled product of high specific activity, tested
for different biological functions (e.g., translocation into
membranes) and then be directly subjected to biochemical
analyses (e.g., electrophoresis followed by autoradiography).
Since in vitro as well as in vivo 3- 507o of transcriptional
readthrough occurs at terminator to some bicistronic mRNA
will exist in both situations. In vivo this results in a moderate
but distinct chloramphenicol resistance of the cell which can
be utilized for controlling the integrity of the transcriptional
unit constructed.
Structure and properties of the plasmid systems pDS5 and
pDS6
All plasmids described here are derived from the plasmid
family pDSl (Stueber and Bujard, 1982; Bujard et al., 1983).
These vectors were designed for the cloning and quantitative
analysis of prokaryotic transcription and translation signals.
The pDSl plasmids contain the bla gene, with its original pro-
moter (P3, Stueber and Bujard, 1981) as an internal tran-
scriptional standard. For analysing various expression
signals, these plasmids carry two indicator genes, dhfr
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Fig. 1. Coupled transcription-translation system for production of a single protein species. DNA sequences of interest can be inserted at six unique restriction
endonuclease cleavage sites of the expression plasmid pDS6 (Figure 2) between a strong coliphage T5-derived promoter (P) and an efficient transcriptional
terminator (T). The integrity of the transcriptional unit constructed can be monitored by low level resistance to chloramphenicol due to the readthrough
occurring at the terminator into the cat gene which lacks its promoter but still contains its ribosomal binding site (RBS). The readthrough transcripts are
efficiently terminated at a second termination site (T) in front of the replication region (on). Transformants can independently be selected for resistance to
ampicillin conferred by the (3-lactamase (bla) gene. Coupled transcription and translation: capped mRNA is produced by transcribing the plasmid with E. coli
RNA polymerase (RNA POL) in the presence of 7mGpppA and the four ribonucleoside triphosphates (NTPs). The RNA is directly translated in a pro- or
eukaryotic cell lysate (for example, the wheat germ system) in the presence of [35S]methionine and the other 19 amino acids (AA) to virtually a single protein
species.
control of a single promoter. There are several advantages to
using these indicator genes: (i) their products are tolerated by
the E. coli cell in large amounts and are easily assayable; (ii)
the respective sizes of their genes are only 665 and 745 bp;
thus, the plasmids are still relatively small, which facilitates
the introduction of additional unique cleavage sites as well as
the insertion of further genetic material. Other advantages of
the pDS systems relating to their structural stability, their
maintenance in E. coli and their potential as efficient expres-
sion systems have been described previously (Bujard et al.,
1983, 1984).
The most relevant properties of the plasmids pDS5 and
pDS6 are described in Figure 2. They all have in common the
region spanning from the XbaI to XhoI cleavage sites, which
corresponds to the PvuII/EcoRI fragment of pBR322. All
constructs contain the promoter/operator fusion PN25X/O
and the cat gene carrying its original ribosomal binding site.
The main differences of the various constructs concern the
region between the promoter and the cat gene and the integra-
tion of transcriptional terminators upstream and downstream
of the cat region. Thus, in pDS5/3 and pDS5/2 the dhfr se-
quence is present with and without a ribosomal binding site,
respectively. This allows the in vivo production of DHFR in
the case of pDS5/3, whereas only CAT is synthesised with
pDS5/2 (Figure 3A). The absence of visible amounts of CAT
in cells carrying pDS5/3 is due to the terminator to between
the dhfr and the cat gene. Elimination of the dhfr sequence
from pDS5/2 results in pDS5/1 which in turn was used for
the construction of pDS5 and pDS6. Both of these plasmids
contain a polylinker with six unique cleavage sites for the con-
venient integration of foreign genes and the terminator t, of
the rrnB operon (Brosius et al., 1981) downstream of the cat
region. The only difference between the two plasmids is the
presence of to in pDS6 to reduce transcriptional readthrough
into the cat region. Integration of the lysozyme gene leads to
pDS5/4 which has been used in the experiments described
below.
Translation of in vitro transcribed mRNA from pDS5/1 -3
in the wheat germ cell-free system
Translation of a mRNA by E. coli ribosomes is dependent on
a functional ribosome binding site. In contrast, eukaryotic
ribosomes are thought to recognize the 5' end of the mRNA,
to move along the mRNA and to initiate protein synthesis at
the first AUG (Kozak, 1983). For an efficient recognition of a
mRNA by eukaryotic ribosomes, the 5' end of the molecule
has to be 'capped' by 7-methylguanosine.
Capping coupled to transcription was achieved in vitro by
including 7mGpppA in the transcription assay (Contreras et
al., 1982). Unlike 7mG which is a potent inhibitor of polypep-
tide chain initiation, 7mGpppA has no inhibitory effect at the
concentrations used (data not shown).
Using coliphage T5 promoter PN25X/O as the transcrip-
tional start signal in plasmids pDS5/1 -3, capped mRNAs
were obtained in the presence of 7mGpppA and E. coli RNA
polymerase in good yields. Since these mRNAs are by far the
most abundant translatable species in the assay, virtually
single proteins are produced in each case using a wheat germ
cell-free translation system. In Figure 3B the individual pro-
teins are shown: DHFR (from pDS5/2), an extended form of
DHFR (from pDS5/3) and CAT (from pDS5/1). As expected
in eukaryotic systems, the translation was always initiated at
the first AUG codon of the corresponding mRNAs. The dif-
ference between pro- and eukaryotic translation initiation is
demonstrated best with pDS5/2: whereas in bacteria only
CAT is synthesised from the bicistronic mRNA (there is no
ribosomal binding site for DHFR), the eukaryotic in vitro
translation system gives rise to only DHFR - provided
7mGpppA is used in transcription (Figure 3A,B).
Translation in the HeLa cellfree system
To test whether the in vitro produced capped mRNA can also
be translated in a mammalian cell-free system, mRNA deriv-
ed from pDS5/2 was translated in a HeLa cell extract. As
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AAAAATT TTGCT TCAGGAAAATTTTTCTGLLLAGATTCAAATTGTGACCGGATAACAATTT-
-mRNA-
EcoRI Polylinker HidjII RBS,cat
GAATTCCCGGGGATCCGTCGACCTGCAGCCAAGCTTGGCGAGATTTTCAGGAGCTAAGGAAGGTAAAATG Ca _ pDS





GAAYTCC.GGATCCGGCATCATG dhfr pOS S/ .
BarnH-I
RBS Hind III
GAATTA||1||||1||1|||| TATGGGATCCGGCATCATG pOS 5/
BaimH I Hind III
EcoRI Hind IU
GAATTCCAAGCTT ATGL:':I: lsrr: : pDS 5/4
Hind III
Fig. 2. Schematic description of plasmids. (A) Genetic and physical map of
pDS5 and pDS6. Both plasmids contain the region between PvuII (now
Xbal) and EcoRI (now XhoI) of pBR322 carrying the replication region
(or,) and the b/a gene. The polylinker from pUC8 (Vieira and Messing,
1982) is placed between PN25X/O (a fusion of coliphage T5 promoter PN25
with the lac operator of E. coli, to be published elsewhere) and the
promoter-free gene for CAT which still contains its original RBS. Cleavage
sites interfering with the utilisation of the polylinker were removed from
the plasmids. Transcripts from P are terminated in vitro and in vivo at
terminator t1 of the rrnB operon of E. coli and in addition also at
terminator to of phage X in the pDS6 system. The lower part of the figure
shows the sequence between the - 43 region of PN25X/O of pDS5 and the
start codon of the cat gene as well as the insertion site of the terminator t
of phage X as it has been used to convert pDS5 to pDS6. (B) Schematic
description of plasmids pDS5/1-4. These plasmids differ from pDS5
within the region between the E. coli and HindIII site. pDS5/1: the 36-bp
fragment of pDS5 is shortened to a 13-bp EcoRI-HindIII fragment.
pDS5/2: the coding region of the dhfr gene (187 amino acids) is inserted.
pDS5/3: a synthetic ribosomal binding site (RBS) is inserted in front of
the dhfr gene resulting in a 192 amino acid fusion protein; transcripts are
terminated in vivo at terminator t0o pDS5/4: the cDNA for chicken
lysozyme (lsm) has been inserted into the HindlIl site of pDS5/1. For
convenience, ATGs from which protein synthesis is initiated are underlined
and relevant restriction cleavage sites are denoted. In contrast to pDS5 and
pDS6 in pDS5/1-4 the Pstl and HindlI sites in the bla gene and the
EcoRI site in the cat gene are still present. Furthermore, plasmids pDS5/1,
2 and 4 contain terminator to at the XbaI site (replacing tQ), whereas in
pDS5/3 this termination signal is located between dhfr and cat.
achieved with an efficiency comparable with that obtained
when an optimal concentration of mRNA from myeloma
tumor MOPC 41 was translated under identical conditions.
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Fig. 3. Synthesis of DHFR and CAT encoded by plasmids
pDS5/1-3. (A) E. co/i cells (C600r-AlacM15) harbouring the respective
l, plasmids were grown overnight in Luria broth containing 100 tzg of
ampicillin/ml, harvested by centrifugation, solubilized in sample buffer and
analysed by SDS-PAGE as described before (Stueber and Bujard, 1982).
The Coomassie blue stained gels show the protein pattern of cells
containing pDS5/2 (lane 1), pDS5/3 (lane 2) and pDS5/1 (lane 3). The
positions of DHFR, its fusion derivative DHFRT (Figure 2) and of CAT
are indicated. As can be seen, all these proteins are synthesised in vivo in
high yields. (B) Plasmids pDS5/1 -3 were transcribed with E. coli RNA
polymerase in the presence of 7mGpppA. The resulting mRNAs were
translated in a wheat germ cell-free system. The [35S]methionine-labelled
proteins were separated by SDS-PAGE and visualized by fluorography
(lane 1. pDS5/2; lane 2: pDS5/3; lane 3: pDS5/1). About 105 c.p.m. were
routinely obtained per 1 al of translation mixture and 5 1l of the assay
mixture were directly applied per slot of the gel. The dried gel was exposed
to Kodak XAR5 film for 60 min.
MOPC 41 mRNA primarily directs the synthesis of light
chains of IgG (Blobel and Dobberstein, 1975) (Figure 4, lane
2).
Translation and membrane translocation ofchicken lysozyme
To study functional features of signal sequences involved in
the translocation of proteins across membranes we cloned the
chicken lysozyme cDNA into the HindIII site of pDS5/1.
After transcription with E. coli RNA polymerase and trans-
lation of the capped mRNA in the wheat germ cell-free
system, a single protein was obtained with the mol. wt. of
prelysozyme (Figure 5, lane 1). To test whether this protein
can be translocated across the membrane of the endoplasmic
reticulum, translation was carried out in the presence of either
Signal Recognition Particle (SRP), or salt washed rough
microsomes (RMk) or of both SRP and RMk.
















Fig. 4. Protein synthesis in the HeLa cell-free system. The translation
system was supplemented with no RNA (lane 1), 10 jtg/ml mRNA from
MOPC 41 myeloma tumour (which produces mainly mRNA for the light
chain of IgG, pLi) (lane 2) and an aliquot of an in vitro transcription assay
with plasmid pDS5/2 as template (lane 3. The second major protein
synthesised under these conditions must be related to DHFR as it can be
precipitated with anti DHFR antibodies). The assays were processed and
evaluated as described in the legend to Figure 3B. The HeLa cell-free
system was as described before (Garoff et al., 1978).
translocated into microsomal vesicles in an SRP-dependent
manner, typical for secretory proteins. As expected SRP
inhibits the production of prelysozyme and RMk by itself can
neither translocate nor process prelysozyme. Mature lyso-
zyme is found inside the microsomal vesicles only if SRP and
RMk are both present during translation, as judged by the
protection of mature lysozyme against exogenous proteinase
K. This protection is eliminated upon solubilization of the
membrane by Triton X-100.
Discussion
The experimental system described here permits the efficient
expression of protein-coding DNA sequences in vitro. The
pertinent element in this system is a strong prokaryotic pro-
moter derived from coliphage T5 which accepts ATP as well
as 7mGpppA for initiation of transcription. Consequently,
depending upon the experimental conditions, capped or
uncapped mRNAs can be produced in a simple transcription
assay using E. coli RNA polymerase. Several promoters of
phage T5 have been found to belong to the strongest transcrip-
tion initiation signals of the E. coli system. In vitro and in vivo
Fig. 5. In vitro synthesis and membrane translocation of lysozyme. Plasmid
pSD5/4 containing the lysozyme cDNA sequence (Figure 2) was transcribed
with E. coli RNA polymerase in the presence of 7mGpppA. The resulting
RNA was translated in a wheat germ cell-free system and the labelled
proteins were analysed by SDS-PAGE as described above. The different
translation assays were supplemented for the translocation process as
follows: lane 1, no addition; lane 2, + SRP; lane 3, + RMk; lane 4, + SRP
+ RMk. After translation in the presence of RMk (lane 5) or SRP and
RMk (lanes 6-7), proteinase K (lanes 5 and 6) or proteinase K and Triton
X-100 (lane 7) were added and the incubation was continued for 90 min on
ice.
they outcompete any other promoter for RNA polymerase if
proper conditions are provided (Gabain and Bujard, 1979;
Gentz et al., 1981; Deuschle and Bujard, in preparation;
Gentz and Bujard, in preparation). Therefore, in the ex-
pression system described here there is only one potentially
translatable RNA produced in addition to the RNA synthe-
sised under the control of the T5 promoter: the bla mRNA.
The promoter of this transcriptional unit, Pbla' is, however,
outcompeted by PN25x/o by a factor of 25 (Deuschle and Bu-
jard, in preparation). Thus, -95% of the in vitro mRNA is
PN25x/O derived.
The plasmid family developed for this expression system
has several advantages over commonly used expression vec-
tors (Roberts et al., 1975; Paterson and Rosenberg, 1979;
Melton et al., 1984; Krieg and Melton, 1984).
(i) The indicator genes encode proteins which are easily
assayable and tolerated in large amounts by E. coli; they can
therefore be brought under the control of highly efficient
expression signals (Bujard et al., 1983).
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(ii) The plasmids contain terminators of transcription in
appropriate sites and can therefore be stably maintained upon
integration of strong promoters (Gentz et al., 1981; Stueber
and Bujard, 1982; Bujard et al., 1984).
(iii) In cloning experiments, bacterial cells harbouring the
desired plasmids can be selected not only by monitoring
ampicillin resistance, but the successful integration of a
sequence between the promoter and the cat gene re-estab-
lishes chloramphenicol resistance in addition; thus the func-
tion of the transcriptional unit can be tested (prior phos-
phatase treatment of the cleaved cloning vehicle is of course
required).
(iv) Sequences cloned in pDS5 will not be translated in E.
coli since no ribosomal binding site is present. This permits
the cloning of sequences coding for proteins poisonous to the
E. coli cell. If fortuitous translation of such a sequence is
suspected, transcription from PN25X/O can be efficiently
repressed by the lac repressor.
(v) There is no ATG between the transcription initiation
site and the last integration site for foreign sequences; thus
translation of the capped RNA will start at a site correspond-
ing to the first ATG of the newly inserted DNA sequence and
we have shown that the distance between the 5' end of the
RNA and the first ATG can vary between 42 and 67 bp with-
out affecting the efficiency of the system (Figure 2).
(vi) For translation in prokaryotic systems, foreign DNA
sequences can be integrated into pDS5/3 derivatives which
carry an efficient ribosomal binding site. Here the repress-
ibility of transcription in vivo is useful since poisonous gene
products can be kept at low enough levels to allow the cells to
survive (Stueber et al., unpublished).
(vii) The DHFR protein, which can be produced in highly
active form and yields of up to 50% of the total cellular
protein (unpublished results) is a useful entity to construct
fusion proteins and has the advantage of being considerably
smaller than, e.g., f-galactosidase. As part of a fusion pro-
tein it can be translocated through membranes as demon-
strated most elegantly in the following paper by Hurt et al.
(1984).
A major advantage of the overall expression system
reported here is the simplicity of the experimental procedure.
The templates required can be isolated by the rapid 'mini
prep' method according to Birnboim and Doly (1979). Ali-
quots of the transcription assay can be directly added to
eukaryotic translation systems without any purification and,
using [35S]methionine, labelled proteins can be synthesised
with high specific activity. Aliquots of this assay can again
directly be subjected to, e.g., SDS-PAGE. Moreover, due to
the efficient labelling of the proteins autoradiograms can be
obtained after <30 min of exposure. Thus, a complete
experiment can be carried out in a day. A word of caution
should be added here: preliminary data suggest that GC-rich
sequences arising from GC-tailing can reduce the efficiency of
translation in this expression system.
We have demonstrated the usefulness of the system with
the coding sequences for three different proteins: dihydro-
folate reductase, chloramphenicol acetyltransferase and lyso-
zyme. Translation was specific and successful in the wheat
germ as well as in the HeLa cell extract and the efficiency of
translation of mRNA obtained by transcription-coupled cap-
ping in vitro was comparable with the translation of mRNA
isolated from mammalian cells (MOPC 41). After the work
reported here had been completed, another efficient but more
tedious transcription system was reported (Melton et al.,
1984; Krieg and Melton, 1984). Transcripts, obtained with
SP6 RNA polymerase, are purified and capped by guanyl-
transferase.
We believe that the method described here will prove to be
useful for a variety of studies of protein structure and func-
tion. Using the lysozyme cDNA sequence we have shown that
protein translocation through membranes can be accomplish-
ed in the assay and further analysis of this process is being
described in a forthcoming publication (Ibrahimi et al., in
preparation). Another interesting application of the system is
demonstrated in the accompanying paper by Hurt et al.
(1984). We are also confident that this expression system will
be useful in the identification of cloned DNA sequences
which code for proteins that are not tolerated in E. coli but
against which antibodies are available.
Materials and methods
E. coli RNA polymerase, 7-methylguanosine 5'-monophosphate and
7mGpppA were from PL-Biochemicals, human placental RNase inhibitor
was from BRL.
Construction of plasmids and preparation of the plasmid DNA
Construction of the various plasmids was performed by standard recombi-
nant DNA methods and, with the exception of pDS5/4, will be described in
detail elsewhere. pDS5/4 was obtained by inserting the HindIII fragment
(Krieg et al., 1984) containing the entire coding region of lysozyme cDNA
(Land et al., 1981) into the HindIII site of pDS5/1 (Figure 2).
Plasmid DNA was prepared either according to Birnboim and Doly (1979)
or by the cleared lysate method (Clewell and Helinski, 1969) followed by
CsCI/ethidium bromide equilibrium centrifugation (Radloff et al., 1967).
Both types of preparations were equally suitable for in vitro transcription and
translation.
Coupled transcription-translation
The transcription-translation system was modified from Contreras et al.
(1982), Roberts et al. (1975) and Muller et al. (1982). 2 Ag of plasmid DNA
were transcribed by 0.3 unit of E. coli RNA polymerase in a final volume of
10 AI containing 20 mM Hepes-KOH, pH 7.5, 10 mM Mg acetate, 200 mM K
acetate, 0.2 mM spermidine, 5 mM dithiothreitol (DTT), 10 units of human
placental RNase inhibitor (RNasin), 0.5 mM each of GTP, CTP, UTP, 5 AM
ATP and 0.25 mM 7mGpppA. After incubation for 5 min at 37°C, I td of
5 mM ATP was added and incubation continued for 15 min at 37°C. The
mixture was put on ice and without further purification used in the translation
assay. A typical 25 IL wheat germ translation assay contained 5 01 of the
transcription mixture, 10 A1 of wheat germ extract, and was adjusted to the
following final concentrations: 20 mM Hepes-KOH pH 7.5, 110 mM K
acetate, 2.8 mM Mg acetate, I mM DTT, I mM ATP, 10 mM creatine phos-
phate, 80 jg/ml creatine phosphokinase, 5 AM S-adenosyl methionine,
20 AM of each of the 19 amino acids minus methionine, 10 ACi [35S]methion-
ine. Where indicated, SRP (5 units per assay) and/or membranes from dog
pancreas (0.05 A,,o per assay) were included. The assays were incubated at
25°C for 60 min. Translation in the HeLa cell free system was done as
described previously (Garoff et al., 1978).
Isolation of SRP (Walter and Blobel, 1983) and membranes from dog pan-
creas (Meyer et al., 1982), post-translational assays (Dobberstein and Blobel,
1977), SDS-polyacrylamide gel electrophoresis (SDS-PAGE; Maizel, 1969)
and fluorography (ENHANCE, NEN) were done as described.
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